Ixekizumab versus guselkumab: 24-week clinical responses and 4-week gene expression data

被引：0
|
作者：
Blauvelt, A. [1 ]
Pinter, A. [2 ]
Tada, Y. [3 ]
Elmaraghy, H. [4 ]
Gallo, G. [4 ]
Nickoloff, B. J. [4 ]
Renda, L. [4 ]
Park, S. [4 ]
Guenther, L. [5 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Univ Hosp, Frankfurt, Germany
[3] Teikyo Univ, Sch Med, Tokyo, Japan
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Guenther Res Inc, London, ON, Canada
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2020年 / 140卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
LB940
引用
收藏
页码：B9 / B9
页数：1
相关论文
共 50 条
  • [1] Indirect comparison of ixekizumab versus guselkumab up to week 12
    Gottlieb, A.
    Ramot, Y.
    Smith, S.
    Saure, D.
    Schacht, A.
    Dossenbach, M.
    Wilhelm, S.
    Thaci, D.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 90 - 90
  • [2] Indirect comparison of Ixekizumab versus Guselkumab up to week 12
    Gottlieb, A. B.
    Ramot, Y.
    Smith, S. D.
    Saure, D.
    Schacht, A.
    Dossenbach, M.
    Wilhelm, S.
    Thaci, D.
    Eppendorfer, S.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 120 - 120
  • [3] Indirect comparison of ixekizumab versus guselkumab up to week 12
    Gottlieb, A.
    Ramot, Y.
    Smith, S.
    Saure, D.
    Schacht, A.
    Dossenbach, M.
    Wilhelm, S.
    Thaci, D.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S3 - S3
  • [4] Inhalation toxicity of polyhexamethylene guanidine-phosphate in rats: A 4-week inhalation exposure and 24-week recovery period study
    Yang, Hyo-Seon
    Yang, Mijin
    Kang, Mihyun
    Kim, Bumseok
    Lee, Kyuhong
    [J]. CHEMOSPHERE, 2023, 312
  • [5] Dehydrated human amnion/chorion membrane treatment of venous leg ulcers: correlation between 4-week and 24-week outcomes
    Serena, T. E.
    Yaakov, R.
    DiMarco, D.
    Le, L.
    Taffe, E.
    Donaldson, M.
    Miller, M.
    [J]. JOURNAL OF WOUND CARE, 2015, 24 (11) : 530 - 534
  • [6] Ixekizumab improves disease severity, clinical symptoms and quality of life in patients with genital psoriasis: A 24-week real-life experience
    Calianno, Gianluca
    Esposito, Maria
    Fidanza, Rosaria
    Palmieri, Maria
    Fargnoli, Maria Concetta
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (04)
  • [7] Acute toxicity of 4-week versus 5-week hypofractionated radiotherapy in localised prostate cancer
    Houshyari, Mohammad
    Mofid, Bahram
    Tabatabaee, Maryam Alavi
    Bakhshandeh, Mohsen
    Taghizadeh-Hesary, Farzad
    [J]. JOURNAL OF RADIOTHERAPY IN PRACTICE, 2022, 21 (04) : 481 - 486
  • [8] Ixekizumab reduces IL-17 and IL-23 pathway genes more rapidly than guselkumab: 4-week results from IXORA-R
    Garcet, Sandra
    Tsoi, Lam C.
    Blauvelt, Andrew
    Papp, Kim A.
    Krishnan, Venkatesh
    Konicek, Bruce
    Dow, Ernst R.
    Gemperline, David
    Elmaraghy, Hany
    Krueger, James
    Gudjonsson, Johann E.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB59 - AB59
  • [9] Olanzapine versus risperidone: weight gain and BMI of schizophrenic patients in a 24-week trial
    Siladji-Mladenovic, D.
    Knezevic, V.
    Ivezic, A.
    Drezgic-Vukic, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S463 - S463
  • [10] A head-to-head comparison of risankizumab and ixekizumab for genital psoriasis: a real-life, 24-week, prospective study
    Sotiriou, E.
    Bakirtzi, K.
    Papadimitriou, I.
    Tsentemeidou, A.
    Eftychidou, P.
    Eleftheriadis, V.
    Lallas, A.
    Ioannides, D.
    Vakirlis, E.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (05) : E359 - E361
12345